Therapeutic Uses of Radiopharmaceuticals in Nuclear Medicine

  • Gopal B. Saha


Hyperthyroidism is a disease manifested by excessive thyroid hormone activity and can arise from a number of pathogenic processes. Several strategies are employed in the treatment of hyperthyroidism, e.g., use of antithyroid drugs such as propylthiouracil or methimazole, thyroidectomy, and use of 131I. Each of these methods has its own merits and disadvantages, but drug therapy and 131I treatment are the most common choices.


Thyroid Cancer Thyroid Carcinoma Bone Pain Polycythemia Vera Radiation Pneumonitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Suggested Reading

  1. Becker D, Hurley JR. Radioiodine treatment of hyperthyroidism. In: Sandler MP, Coleman RE, Walkers FJT, et al., eds. Diagnostic Nuclear Medicine. 3rd ed. Baltimore: Williams and Wilkins; 1996:943.Google Scholar
  2. Boerman OC, van Schaijk FD, Oyen WJG, et al. Pretargeted radioimmunotherapy of cancer: progress step by step. J Nucl Med. 2003; 44:400.PubMedGoogle Scholar
  3. Farhanghi M, Holmes RA, Volkert WA, et al. Samarium-153-EDTMP: pharmacokinetics, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone pain. J Nucl Med. 1992; 33:1451.PubMedGoogle Scholar
  4. Goldsmith SJ. Radioimmunotherapy of lymphoma: Bexxar and Zevalin. Semin Nucl Med. 2010; 40:122.PubMedCrossRefGoogle Scholar
  5. Hurley JR, Becker DV. Treatment of thyroid cancer with radioiodine (131I). In: Sandler MP, Coleman RE, Walkers FJT, et al., eds. Diagnostic Nuclear Medicine. 3rd ed. Baltimore: Williams and Wilkins; 1996:959.Google Scholar
  6. Maxon HR III, Smith HD. Radioiodine-131 in the diagnosis and treatment of metastatic well-differentiated thyroid cancer. Endocrinol Metab Clin North Am. 1990; 19:685.PubMedGoogle Scholar
  7. Package inserts for Theraspheres and SIR-Spheres. Robinson RG, Preston DF, Schiéfelbein M, et al. Strontium-89 therapy for the palliation of pain due to osseous metastases. JAMA. 1995; 274:420.PubMedCrossRefGoogle Scholar
  8. Salem R, Hunter RD. Yittrium-90-micrrospheres for the treatment of hepatocellular carcinoma: a review. Int J Radiat Oncol Biol Phys. 2006; 66:583.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Gopal B. Saha
    • 1
  1. 1.Department of Nuclear MedicineThe Cleveland Clinic FoundationClevelandUSA

Personalised recommendations